CN Patent

CN106137991A — 一种利格列汀片制粒方法

Assigned to HEFEI YUANZHI PHARMACEUTICAL R & D Co Ltd · Expires 2016-11-23 · 9y expired

What this patent protects

一种利格列汀片制粒方法。按照重量份计称取甘露醇100‑140份，预胶化淀粉15‑40份，玉米淀粉5‑20份，然后将甘露醇、预胶化淀粉、玉米淀粉放入预先预热过的流化床中，混合后，喷入粘合剂聚维酮和利格列汀的悬液混制粒，然后干燥至颗粒水分2‑4%，30目整粒后，加入1.5%硬脂酸镁混合，即得利格列汀颗粒。本发明方法制粒集混合、制粒、干燥于一体，减少了制粒过程的裸露环节，操作更简单、可控。

USPTO Abstract

一种利格列汀片制粒方法。按照重量份计称取甘露醇100‑140份，预胶化淀粉15‑40份，玉米淀粉5‑20份，然后将甘露醇、预胶化淀粉、玉米淀粉放入预先预热过的流化床中，混合后，喷入粘合剂聚维酮和利格列汀的悬液混制粒，然后干燥至颗粒水分2‑4%，30目整粒后，加入1.5%硬脂酸镁混合，即得利格列汀颗粒。本发明方法制粒集混合、制粒、干燥于一体，减少了制粒过程的裸露环节，操作更简单、可控。

Drugs covered by this patent

Patent Metadata

Patent number
CN106137991A
Jurisdiction
CN
Classification
—
Expires
2016-11-23
Drug substance claim
No
Drug product claim
No
Assignee
HEFEI YUANZHI PHARMACEUTICAL R & D Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.